NUVB
NYSE · Pharmaceuticals
Nuvation Bio Inc
$6.60
+0.49 (+8.02%)
Open$6.30
Previous Close$6.11
Day High$6.64
Day Low$6.21
52W High$9.75
52W Low$2.18
Volume—
Avg Volume5.88M
Market Cap2.13B
P/E Ratio—
EPS$-0.43
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+554.8% upside
Current
$6.60
$6.60
Target
$43.22
$43.22
$30.63
$43.22 avg
$69.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 62.09M | 781.90M | 798.00M |
| Net Income | -201,935,882 | 141.36M | 136.11M |
| Profit Margin | -325.3% | 18.1% | 17.1% |
| EBITDA | -208,542,364 | 195.91M | 227.47M |
| Free Cash Flow | — | 85.45M | 83.04M |
| Rev Growth | — | +23.6% | -6.7% |
| Debt/Equity | 0.68 | 0.84 | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |